Medicina de Familia-SEMERGEN最新文献_第7页

Carga de la enfermedad por VIH/sida en los departamentos de Colombia, 2018-2022 [2018-2022年哥伦比亚各省艾滋病毒/艾滋病造成的疾病负担]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102335

O.A. Gutierrez-Lesmes , J. Martínez-Torres , L.I. Plata Casas

{"title":"Carga de la enfermedad por VIH/sida en los departamentos de Colombia, 2018-2022","authors":"O.A. Gutierrez-Lesmes , J. Martínez-Torres , L.I. Plata Casas","doi":"10.1016/j.semerg.2024.102335","DOIUrl":"10.1016/j.semerg.2024.102335","url":null,"abstract":"<div><h3>Introduction</h3><div>HIV/AIDS is a disease that continues to be a threat to public health.</div></div><div><h3>Objective</h3><div>Estimate the burden of disease generated by HIV/AIDS in the departments of Colombia, 2018 - 2022.</div></div><div><h3>Methodology</h3><div>Disease burden study, based on the metrics of global health estimates from the World Health Organization. State morbidity and mortality databases were used.</div></div><div><h3>Results</h3><div>The departments of Colombia lost 1051,599 (II 95% 849,217.41-1,253,980) DALYs due to HIV/AIDS. When classifying the departments by DALYs rates per 100,000 inhabitants, the differences in the burden in the departments become visible, departments, with rates in the study period, ranging from 4029.8 (3274.4-4785.2) DALYs, in the case of the department of Quindío and 297.2 (103.9-490.5) DALYs in the department of Vichada, men lost on average 23,833.48 (II 95% 13813-35809), while women lost 8,033 (II95% 5214-11177), 75% of DALYs in men occur between 20 and 49 years, in women 71.4% in the same age group.</div></div><div><h3>Conclusions</h3><div>There are differences in the loss of years of healthy life between the departments of Colombia, and annual variations in each department.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 1","pages":"Article 102335"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Alteraciones en la ecogenicidad testicular asociadas al síndrome de hipogonadismo de inicio tardío del varón [与睾丸回声改变有关的晚发性性腺功能减退综合征]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102338

J. Monllor Méndez , J. Carballido Rodríguez , J. González-Spinola San Gil , A. Monllor Méndez

{"title":"Alteraciones en la ecogenicidad testicular asociadas al síndrome de hipogonadismo de inicio tardío del varón","authors":"J. Monllor Méndez , J. Carballido Rodríguez , J. González-Spinola San Gil , A. Monllor Méndez","doi":"10.1016/j.semerg.2024.102338","DOIUrl":"10.1016/j.semerg.2024.102338","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to investigate the relationship between the presence of late-onset hypogonadism (LOH) syndrome in men and alterations in testicular echogenicity in a rural population sample.</div></div><div><h3>Materials and methods</h3><div>Prospective observational cohort study in which men between 45 and 75 years old from Villarta de San Juan area (Ciudad Real) were included. In order to determine the incidence of HIT, each patient was administered the AMSS test, a blood test to determine the concentration of testosterone, and a bilateral testicular ultrasound was performed.</div></div><div><h3>Results</h3><div>287 patients were included in the study. The diagnosis of LOH syndrome was established in 9.76% of them. 154 bilateral testicular ultrasounds were performed in which their testicular echogenicity patterns were evaluated. In 72.7% of the cases, alterations could be described in accordance with the standards proposed by the European Academy of Andrology of the year 2022. Testicular echogenicity evaluated by ultrasound demonstrated a sensitivity of 72.7%, a specificity of 78.8%, a negative predictive value of 94.5% and a positive predictive value of 36.4%, for the diagnosis of LOH.</div></div><div><h3>Conclusions</h3><div>The determination of testicular echogenicity in patients with suspected LOH syndrome showed much greater specificity than the AMSS test and a similar negative predictive value. Based on its innocuousness and the fact that it is a relatively simple examination from a technical point of view, it could be postulated as a diagnostic tool to be taken into account in the identification of this syndrome.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 1","pages":"Article 102338"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Necrosis aséptica de hombros y caderas simulando una polimialgia reumática [模拟多发性风湿性关节炎的肩部和髋部无菌性坏死]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102313

E. Cañadillas Sánchez, E.M. Oliver García, C.A. Peralta Ginés, M.C. Osorio Sanjuan, P. del Río Martínez

引用次数: 0

Diagnóstico de la hipertensión durante el embarazo y preeclampsia, los límites del control y tratamiento [妊娠期高血压和子痫前期的诊断、控制和治疗的限度]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102330

M.A. María-Tablado

引用次数: 0

Nuevas competencias emergentes para el médico de familia [家庭医生的新能力]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102329

M. Algaba Montes , A.Á. Oviedo García , C. Montero Peña

引用次数: 0

Sintomatología esofágica como síntoma guía de tuberculosis ganglionar [食道症状是淋巴结结核的主要症状]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102314

P. Pérez Solís, B.N. Brizzi

引用次数: 0

Revisión del ejercicio físico como tratamiento de la lumbalgia en la mujer embarazada [回顾体育锻炼对孕妇腰背痛的治疗]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102340

L.M. Gallo-Galán , J.L. Gallo-Vallejo , J. Mozas-Moreno

引用次数: 0

Equidad y reticencia vacunal: más ética, por favor [公平与疫苗犹豫不决：请提供更多伦理信息]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102344

M. Cruz-Piqueras , J. Hortal-Carmona

引用次数: 0

Optimization of adherence to fixed-dose combination therapy in the treatment of cardiovascular risk factors in primary care 在初级保健中优化固定剂量联合疗法在心血管风险因素治疗中的依从性。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102337

F.J. Alonso Moreno , J. Espinosa García , F. López Simarro , L. Aliaga Gutiérrez , C. Montero Peña , A. Manzano Vilches , M. Ricote Belinchón , P. Panero Hidalgo , C. Escobar Cervantes

{"title":"Optimization of adherence to fixed-dose combination therapy in the treatment of cardiovascular risk factors in primary care","authors":"F.J. Alonso Moreno , J. Espinosa García , F. López Simarro , L. Aliaga Gutiérrez , C. Montero Peña , A. Manzano Vilches , M. Ricote Belinchón , P. Panero Hidalgo , C. Escobar Cervantes","doi":"10.1016/j.semerg.2024.102337","DOIUrl":"10.1016/j.semerg.2024.102337","url":null,"abstract":"<div><h3>Objective</h3><div>Provide consensus recommendations for the optimal management of fixed-dose combination therapies (FCT) in patients with cardiovascular risk factors (CVRF) in primary care (PC).</div></div><div><h3>Material and methods</h3><div>A modified Delphi technique was used. A scientific committee wrote 80 statements addressing controversial issues regarding adherence and the use of FCT in patients with CVRF. A panel of 52 PC specialists, experts in CVRF management and adherence evaluated the questionnaire in two rounds. The work was promoted by the Network of Experts in Adherence in Primary Care (REAAP).</div></div><div><h3>Results</h3><div>Agreement was reached on 66 of the 80 issues (82.5%). The panellists considered that the adherence of patients with CVRF treated in PC was inadequate, which could have clinical implications. The use of FCT might increase adherence compared to separate treatments. FCT usage promotion in PC was considered necessary, especially in polymedicated patients. Measures such as establishing specific protocols or improving the training of professionals in the FTC use are necessary. The FTC use was recommended as a reduction in long-term cardiovascular events in hypertension was observed, together with changes of the concept of high-intensity statins to high-intensity lipid-lowering therapy in dyslipidemia, or considering the use of FCT if the option was available in type 2 diabetes mellitus.</div></div><div><h3>Conclusions</h3><div>The expert consensus recommendations from this work may facilitate the use of FCT in patients with CVRF in PC.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 1","pages":"Article 102337"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Inteligencia artificial para el abordaje integral de las enfermedades huérfanas/raras: revisión sistemática exploratoria [人工智能用于孤儿/罕见病的综合方法：范围审查]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-28 DOI: 10.1016/j.semerg.2024.102434

L.M. Acero Ruge , D.A. Vásquez Lesmes , E.H. Hernández Rincón , L.P. Avella Pérez

{"title":"Inteligencia artificial para el abordaje integral de las enfermedades huérfanas/raras: revisión sistemática exploratoria","authors":"L.M. Acero Ruge , D.A. Vásquez Lesmes , E.H. Hernández Rincón , L.P. Avella Pérez","doi":"10.1016/j.semerg.2024.102434","DOIUrl":"10.1016/j.semerg.2024.102434","url":null,"abstract":"<div><h3>Introduction</h3><div>Orphan diseases (OD) are rare but collectively common, presenting challenges such as late diagnoses, disease progression, and limited therapeutic options. Recently, artificial intelligence (AI) has gained interest in the research of these diseases.</div></div><div><h3>Objective</h3><div>To synthesize the available evidence on the use of AI in the comprehensive approach to orphan diseases.</div></div><div><h3>Methods</h3><div>An exploratory systematic review of the Scoping Review type was conducted in PubMed, Bireme, and Scopus from 2019 to 2024.</div></div><div><h3>Results</h3><div>fifty-six articles were identified, with 21.4% being experimental studies; 28 documents did not specify an OD, 8 documents focused primarily on genetic diseases; 53.57% focused on diagnosis, and 36 different algorithms were identified.</div></div><div><h3>Conclusions</h3><div>The information found shows the development of AI algorithms in different clinical settings, confirming the potential benefits in diagnosis times, therapeutic options, and greater awareness among health professionals.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 5","pages":"Article 102434"},"PeriodicalIF":0.9,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0